These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35037069)

  • 1. We Asked the Experts: Toward Personalized Immunosuppression for Liver Transplant Recipients.
    Lew J; Perito ER; Feng S
    World J Surg; 2022 Apr; 46(4):876-877. PubMed ID: 35037069
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppression in HIV-Positive Heart Transplant Recipients During the Post-COVID-19 Era.
    Mahrokhian SH; Nordan T; Kawabori M
    Ann Thorac Surg; 2022 Aug; 114(2):607-608. PubMed ID: 34310920
    [No Abstract]   [Full Text] [Related]  

  • 3. Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward.
    Stegall MD; Morris RE; Alloway RR; Mannon RB
    Am J Transplant; 2016 Apr; 16(4):1094-101. PubMed ID: 26730885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction immunosuppression in kidney transplant recipients with HIV: To deplete or not to deplete?
    Agrawal A; Stosor V
    Transpl Infect Dis; 2024 Aug; 26(4):e14299. PubMed ID: 38953433
    [No Abstract]   [Full Text] [Related]  

  • 5. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
    Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
    Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Use of Immunosuppression in Liver Transplantation.
    Adjei M; Kim IK
    Surg Clin North Am; 2024 Feb; 104(1):11-25. PubMed ID: 37953030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the characteristics of adult liver transplant recipients with prope (almost) tolerance and full immunosuppression regimen.
    Shamsaeefar A; Nikoupour H; Kazemi K; Gholami S; Moosavi SA; Motazedian N; Sayadi M; Afshinnia F; Nikeghbalian S; Malekhosseini SA
    Transpl Immunol; 2021 Oct; 68():101440. PubMed ID: 34343659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression in pediatric liver transplant recipients: Unique aspects.
    Miloh T; Barton A; Wheeler J; Pham Y; Hewitt W; Keegan T; Sanchez C; Bulut P; Goss J
    Liver Transpl; 2017 Feb; 23(2):244-256. PubMed ID: 27874250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present state of immunosuppressive therapy in liver transplant recipients.
    Wiesner RH; Fung JJ
    Liver Transpl; 2011 Nov; 17 Suppl 3():S1-9. PubMed ID: 21850697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
    Charlton M; Levitsky J; Aqel B; OʼGrady J; Hemibach J; Rinella M; Fung J; Ghabril M; Thomason R; Burra P; Little EC; Berenguer M; Shaked A; Trotter J; Roberts J; Rodriguez-Davalos M; Rela M; Pomfret E; Heyrend C; Gallegos-Orozco J; Saliba F
    Transplantation; 2018 May; 102(5):727-743. PubMed ID: 29485508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in immunosuppression practices among pediatric liver transplant centers-Society of Pediatric Liver Transplantation survey results.
    Slowik V; Lerret SM; Lobritto SJ; Voulgarelis S; Vitola BE
    Pediatr Transplant; 2021 Mar; 25(2):e13873. PubMed ID: 33026158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression.
    Cillo U; Bechstein WO; Berlakovich G; Dutkowski P; Lehner F; Nadalin S; Saliba F; Schlitt HJ; Pratschke J
    Transplant Rev (Orlando); 2018 Jul; 32(3):142-150. PubMed ID: 29709248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Rejection Management: Prevention and Treatment.
    Harrington CR; Yang GY; Levitsky J
    Clin Liver Dis; 2021 Feb; 25(1):53-72. PubMed ID: 33978583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of Liver Biopsies in Liver Transplant Recipients.
    Voigtländer T; Alten TA; Kirstein MM; Lehner F; Manns MP; Schlué J; Wedemeyer H; Lankisch TO
    Ann Transplant; 2017 Feb; 22():108-114. PubMed ID: 28232660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Generic Immunosuppressive Drugs the Solution for Providing Lifelong Medication Coverage to Transplant Recipients?
    Potter LM
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):327-329. PubMed ID: 30819668
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction and maintenance immunosuppression in pediatric kidney transplantation-Advances and controversies.
    Balani SS; Jensen CJ; Kouri AM; Kizilbash SJ
    Pediatr Transplant; 2021 Nov; 25(7):e14077. PubMed ID: 34216190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients.
    Smedman TM; Line PD; Guren TK; Dueland S
    Acta Oncol; 2018 Oct; 57(10):1414-1418. PubMed ID: 29912605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.